中国脑小血管病诊治专家共识2021

doi:10.3969/j.issn.1673-5765.2021.07.013

摘要/Abstract

中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(07): 716-726.

Cerebral Small Vessel Disease Professional Committee Consensus Writing Group, Chinese Research Hospital Association. Chinese Consensus on Diagnosis and Therapy of Cerebral Small Vessel Disease 2021[J]. Chinese Journal of Stroke, 2021, 16(07): 716-726.

参考文献

[1] 中华医学会神经病学分会，中华医学会神经病学分
会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华
神经科杂志，2015，48（10）：838-844.
[2] PANTONI L. Cerebral small vessel disease：from
pathogenesis and clinical characteristics to
therapeutic challenges[J]. Lancet Neurol，2010，9
（7）：689-701.
[3] WARDLAW J M，SMITH E E，BIESSELS G J，et
al. Neuroimaging standards for research into small
vessel disease and its contribution to ageing and
neurodegeneration[J]. Lancet Neurol，2013，12（8）：
822-838.
[4] WU S M，WU B，LIU M，et al. Stroke in China：
advances and challenges in epidemiology，prevention，
and management[J]. Lancet Neurol，2019，18（4）：
394-405.
[5] POELS M M F，VERNOOIJ M W，IKRAM M
A，et al. Prevalence and risk factors of cerebral
microbleeds：an update of the Rotterdam scan
study[J/OL]. Stroke，2010，41（10 Suppl）：
S103-S106[2021-06-17]. https：//doi.org/10.1161/
strokeaha.110.595181.
[6] ZHANG C Q，CHEN Q D，WANG Y L，et al. Risk
factors of dilated Virchow-Robin spaces are different
in various brain regions[J/OL]. PLoS One，2014，9
（8）：e105505[2021-06-17]. https：//doi.org/10.1371/
journal.pone.0105505.
[7] WANG Y L，XU J，ZHAO X Q，et al. Association
of hypertension with stroke recurrence depends on
ischemic stroke subtype[J]. Stroke，2013，44（5）：
1232-1237.
[8] MA Y，SONG A，VISWANATHAN A，et al. Blood
pressure variability and cerebral small vessel disease：
a systematic review and meta-analysis of populationbased
cohorts[J]. Stroke，2020，51（1）：82-89.
[9] IADECOLA C. The neurovascular unit coming of
age：a journey through neurovascular coupling in
health and disease[J]. Neuron，2017，96（1）：17-42.
[10] MORAN C，PHAN T G，SRIKANTH V K.
Cerebral small vessel disease：a review of clinical，
radiological，and histopathological phenotypes[J].
Int J Stroke，2012，7（1）：36-46.
[11] 牛世芹，秦伟，杨淑娜，等. 脑小血管病导致运动障
碍的研究进展[J]. 中华老年心脑血管病杂志，2019，
21（6）：670-672.
[12] SCHMIDT R，BERGHOLD A，JOKINEN H，et al.
White matter lesion progression in LADIS：frequency，
clinical effects，and sample size calculations[J].
Stroke，2012，43（10）：2643-2647.
[13] LADIS Study Group. 2001–2011：a decade of the
LADIS（Leukoaraiosis And DISability）Study：what
have we learned about white matter changes and
small-vessel disease?[J]. Cerebrovas Dis，2011，32
（6）：577-588.
[14] VAN ES A C，VAN DER GROND J，DE CRAEN
A J M，et al. Cerebral microbleeds and cognitive
functioning in the PROSPER study[J]. Neurology，
2011，77（15）：1446-1452.
[15] NANNONI S，OHLMEIER L，BROWN R B，et al.
Cognitive impact of cerebral microbleeds in patients
with symptomatic small vessel disease[J/OL]. Int J
Stroke，2021：17474930211012837[2021-06-17].
https：//doi.org/10.1177/17474930211012837.
[16] DE LAAT K F，VAN DEN BERG H A C，VAN
NORDEN A G W，et al. Microbleeds are
independently related to gait disturbances in elderly
individuals with cerebral small vessel disease[J].
Stroke，2011，42（2）：494-497.
[17] PASSIAK B S，LIU D，KRESGE H A，et al.
Perivascular spaces contribute to cognition beyond
other small vessel disease markers[J/OL]. Neurology，
2019，92（12）：e1309-e1321[2021-06-17]. https：//doi.
org/10.1212/wnl.0000000000007124.
[18] HILAL S，TAN C S，ADAMS H H H，et al.
Enlarged perivascular spaces and cognition：a
meta-analysis of 5 population-based studies[J/OL].
Neurology，2018，91（9）：e832-e842[2021-06-17].
https：//doi.org/10.1212/wnl.0000000000006079.
[19] SCHELTENS P，BARKHOF F，LEYS D，et al.
A semiquantative rating scale for the assessment
of signal hyperintensities on magnetic resonance
imaging[J]. J Neurol Sci，1993，114（1）：7-12.

[20] VAN STRAATEN E，FAZEKAS F，ROSTRUP E，

et al. Impact of white matter hyperintensities scoring
method on correlations with clinical data：the
LADIS study[J]. Stroke，2006，37（3）：836-840.
[21] GREGOIRE S，CHAUDHARY U，BROWN M，et
al. The microbleed anatomical rating scale（MARS）：
reliability of a tool to map brain microbleeds[J].
Neurology，2009，73（21）：1759-1766.
[22] CORDONNIER C，POTTER G，JACKSON C，et
al. Improving interrater agreement about brain
microbleeds：development of the brain observer
microbleed scale（BOMBS）[J]. Stroke，2009，40
（1）：94-99.
[23] DUERING M，FINSTERWALDER S，BAYKARA
E，et al. Free water determines diffusion alterations
and clinical status in cerebral small vessel disease[J].
Alzheimers Dement，2018，14（6）：764-774.
[24] REIJMER Y，FOTIADIS P，MARTINEZRAMIREZ
S，et al. Structural network alterations
and neurological dysfunction in cerebral amyloid
angiopathy[J/OL]. Brain，2015，138（Pt 1）：179-
188[2021-06-17]. https：//doi.org/10.1093/brain/
awu316.
[25] LI Y X，WANG D F，ZHANG H Y，et al. Changes
of brain connectivity in the primary motor cortex
after subcortical stroke：a multimodal magnetic
resonance imaging study[J/OL]. Medicine，2016，95
（6）：e2579[2021-06-17]. https：//doi.org/10.1097/md.
0000000000002579.
[26] LI Y，LI M，ZUO L，et al. Compromised blood-brain
barrier integrity is associated with total magnetic
resonance imaging burden of cerebral small vessel
disease[J/OL]. Front Neurol，2018，9：221[2021-06-
17]. https：//doi.org/10.3389/fneur.2018.00221.
[27] 中华医学会老年医学分会老年神经病学组，脑小血
管病认知功能障碍诊疗指南中国撰写专家组. 脑小
血管病相关认知功能障碍中国诊疗指南（2019）[J].
中华老年医学杂志，2019，38（4）：345-354.
[28] 乔杉杉，张拥波，赵莹莹，等. 脑小血管病临床生化
标志物研究进展[J]. 临床和实验医学杂志，2020，19
（6）：671-673.
[29] MARINI S，ANDERSON C，ROSAND J. Genetics
of cerebral small vessel disease[J]. Stroke，2020，51
（1）：12-20.
[30] STAALS J，MAKIN S D J，DOUBAL F N，et al.
Stroke subtype，vascular risk factors，and total MRI
brain small-vessel disease burden[J]. Neurology，
2014，83（14）：1228-1234.
[31] FAZEKAS F，CHAWLUK J B，ALAVI A，et al. MR
signal abnormalities at 1.5 T in Alzheimer's dementia
and normal aging[J]. AJR Am J Roentgenol，1987，
149（2）：351-356.
[32] DOUBAL F N，MACLULLICH A M J，FERGUSON
K J，et al. Enlarged perivascular spaces on MRI are
a feature of cerebral small vessel disease[J]. Stroke，
2010，41（3）：450-454.
[33] YANG S N，YUAN J L，QIN W，et al. Twentyfour-
hour ambulatory blood pressure variability is
associated with total magnetic resonance imaging
burden of cerebral small-vessel disease[J/OL]. Clin
Interv Aging，2018，13：1419-1427[2021-06-17].
https：//doi.org/10.2147/CIA.S171261.
[34] SØNDERGAARD C B，NIELSEN J E，HANSEN
C K，et al. Hereditary cerebral small vessel disease
and stroke[J/OL]. Clin Neurol Neurosurg，2017，155：
45-57[2021-06-17]. https：//doi.org/10.1016/j.clineuro.
2017.02.015.
[35] ODDEN M C，MCCLURE L A，SAWAYA B P，et
al. Achieved blood pressure and outcomes in the
secondary prevention of small subcortical strokes
trial[J]. Hypertension，2016，67（1）：63-69.
[36] DECARLI C. Blood pressure control and cognitive
performance：something to think about with
aging[J]. JAMA，2015，313（19）：1963-1964.
[37] CHEN X，ZHU Y Q，GENG S S，et al. Association
of blood pressure variability and intima-media
thickness with white matter hyperintensities in
hypertensive patients[J/OL]. Front Aging Neurosci，
2019，11：192[2021-06-17]. https：//doi.org/10.3389/
fnagi.2019.00192.
[38] ZHANG H，CUI Y，ZHAO Y X，et al. Association
of circadian rhythm of blood pressure and cerebral
small vessel disease in community-based elderly
population[J]. J Gerontol A Biol Sci Med Sci，2019，
74（8）：1322-1330.
[39] YANG S A，YUAN J L，ZHANG X Y，et al. Higher
ambulatory systolic blood pressure independently
associated with enlarged perivascular spaces in basal
ganglia[J]. Neurol Res，2017，39（9）：787-794.
[40] KU E，SCHERZER R，ODDEN M C，et al. Patterns
of blood pressure response during intensive BP
lowering and clinical events：results from the
secondary prevention of small subcortical strokes
trial[J]. Blood Press，2018，27（2）：73-81.
[41] WEBB A J S，FISCHER U，MEHTA Z，et
al. Effects of antihypertensive-drug class on
interindividual variation in blood pressure and risk
of stroke：a systematic review and meta-analysis[J].
Lancet，2010，375（9718）：906-915.
[42] POWERS W J，RABINSTEIN A A，ACKERSON
T，et al. 2018 Guidelines for the early management of
patients with acute ischemic stroke：a guideline for
healthcare professionals from the American Heart
Association/American Stroke Association[J/OL].
Stroke，2018，49（3）：e46-e110[2021-06-17].
https：//doi.org/10.1161/str.0000000000000158.
[43] 中华医学会神经病学分会，中华医学会神经病学分
会脑血管病学组. 中国急性缺血性脑卒中诊治指南
2018[J]. 中华神经科杂志，2018，51（9）：666-682.
[44] KIM B J，KWON S U，PARK J-H，et al. Cilostazol
versus aspirin in ischemic stroke patients with highrisk
cerebral hemorrhage：subgroup analysis of the
PICASSO trial[J]. Stroke，2020，51（3）：931-937.
[45] AMARENCO P，BENAVENTE O，GOLDSTEIN
L B，et al. Results of the stroke prevention by
aggressive reduction in cholesterol levels（SPARCL）
trial by stroke subtypes[J]. Stroke，2009，40（4）：
1405-1409.
[46] XIONG Y Y，WONG A，CAVALIERI M，et
al. Prestroke statins，progression of white
matter hyperintensities，and cognitive decline
in stroke patients with confluent white matter
hyperintensities[J]. Neurotherapeutics，2014，11（3）：
606-611.
[47] TEN DAM V H，VAN DEN HEUVEL D M J，
VAN BUCHEM M A，et al. Effect of pravastatin
on cerebral infarcts and white matter lesions[J].
Neurology，2005，64（10）：1807-1809.
[48] Heart Protection Study Collaborative Group. MRC/
BHF heart protection study of cholesterol lowering
with simvastatin in 20，536 high-risk individuals：a
randomised placebo-controlled trial[J]. Lancet，2002，
360（9326）：7-22.
[49] PEZZINI A，GRASSI M，IACOVIELLO L，et al.
Serum cholesterol levels，HMG-CoA reductase
inhibitors and the risk of intracerebral haemorrhage.
the multicenter study on cerebral haemorrhage
in Italy（MUCH-Italy）[J]. J Neurol Neurosurg
Psychiatry，2016，87（9）：924-929.
[50] ZHANG J L，LIU N N，YANG C Q. Effects of
rosuvastatin in combination with nimodipine in
patients with mild cognitive impairment caused by
cerebral small vessel disease[J]. Panminerva Med，
2019，61（4）：439-443.
[51] ZHANG H，CUI Y，ZHAO Y X，et al. Effects
of sartans and low-dose statins on cerebral white
matter hyperintensities and cognitive function in
older patients with hypertension：a randomized，
double-blind and placebo-controlled clinical trial[J].
Hypertens Res，2019，42（5）：717-729.
[52] JIAN B H，HU M Y，CAI W，et al. Update of
immunosenescence in cerebral small vessel disease[J/
OL]. Front Immunol，2020，11：585655[2021-06-17].
https：//doi.org/10.3389/fimmu.2020.585655.
[53] CAVALIERI M，SCHMIDT R，CHEN C，et al. B
vitamins and magnetic resonance imaging-detected
ischemic brain lesions in patients with recent
transient ischemic attack or stroke：the VITAmins
TO Prevent Stroke（VITATOPS）MRI-substudy[J].
Stroke，2012，43（12）：3266-3270.